0001209191-19-055002.txt : 20191104
0001209191-19-055002.hdr.sgml : 20191104
20191104174608
ACCESSION NUMBER: 0001209191-19-055002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191101
FILED AS OF DATE: 20191104
DATE AS OF CHANGE: 20191104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rakhit Amit
CENTRAL INDEX KEY: 0001704636
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 191190896
MAIL ADDRESS:
STREET 1: C/O OVID THERAPEUTICS INC.
STREET 2: 1460 BROADWAY, SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-01
0
0001636651
Ovid Therapeutics Inc.
OVID
0001704636
Rakhit Amit
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044
NEW YORK
NY
10036
0
1
0
0
President and CMO
Common Stock (right to buy)
2.46
2019-11-01
4
A
0
75000
0.00
A
2029-10-31
Common Stock
75000
75000
D
25% of the shares subject to the Stock Option will vest and become exercisable on November 1, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
/s/ Danielle Mann for Amit Rakhit by POA
2019-11-04